Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib

Kazunori Murai, MD PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD PhD, Tomoaki Akagi, Kazuei Ogawa, MD PhD, Inomata Mitsue, Kuniaki Meguro, Reiko Watanabe, MD PhD, Takuto Miyagishima, MD, PhD, Kentaro Wakasa, Motohiro Shindo, MD PhD, Yasuhiko Tsukushi, MD PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD

Blood (2015) 126 (23): 4052.

https://doi.org/10.1182/blood.V126.23.4052.4052

Published: 2015

Journal Articles

Clinical Efficacy and Safety Of Dasatinib For Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase In Japan

Kohei Yamaguchi, M.D., Kazunori Murai, M.D., Ph.D., Shigeki Ito, M.D., Ph.D., Tomoaki Akagi, M.D., Ph.D., Kazuei Ogawa, M.D., Ph.D., Kuniaki Meguro, M.D., Ph.D., Mitsue Inomata, M.D., Reiko Watanabe, M.D., Ph.D., Takuto Miyagishima, M.D., Kentaro Wakasa, M.D., Motohiro Shindo, M.D., Ph.D., Yasuhiko Tsukushi, M.D., Kohmei Kubo, M.D., Ph.D., Yoji Ishida, M.D., Ph.D.

Blood (2013) 122 (21): 1493.

https://doi.org/10.1182/blood.V122.21.1493.1493

Published: 2013

Journal Articles

The Prospective Analysis Of Clinical Efficacy and Adverse Events In Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Patients With Imatinib Resistance Or Intolerance, Evaluated By European Leukemia Net (ELN) 2013 Criteria

Kazunori Murai, M.D., Ph.D., Tomoaki Akagi, M.D., Ph.D., Kenji Shimosegawa, MD, Kenichi Ishizawa, MD, PhD, Tomohiro Sugawara, MD, Hisayuki Yokoyama, MD, PhD, Hideyoshi Noji, MD, PhD, Kazuei Ogawa, M.D., Ph.D., Katsushi Tajima, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MD, PhD, Koumei Kubo, MD, PhD, Hisashi Sakamaki, MD, PhD, Hideo Harigae, MD, PhD, Yoji Ishida, M.D., Ph.D.

Blood (2013) 122 (21): 4027.

https://doi.org/10.1182/blood.V122.21.4027.4027

Published: 2013

Journal Articles

Efficacy and Safety of Dasatinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance

Tomoaki Akagi, MD, PhD, Kazunori Murai, MD, PhD, Kenji Shimosegawa, MD, Kenichi Ishizawa, MD, PhD, Tomohiro Sugawara, MD, Hisayuki Yokoyama, MD, PhD, Hideyoshi Noji, MD, PhD, Kazuei Ogawa, MD, Katsusi Tazima, MD, PhD, Koji Ooba, MD, Junichi Sakamoto, MD, PhD, Kubo Koumei, MD, PhD, Hisashi Sakamaki, MD, Hideo Harigae, MD, PhD, Yoji Ishida, MD, PhD

Blood (2011) 118 (21): 4444.

https://doi.org/10.1182/blood.V118.21.4444.4444

Published: 2011

Journal Articles

Micafungin Versus Voriconazole for Empirical Antifungal Therapy In Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized, Controlled Trial.

Tatsuo Oyake, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Tomoaki Akagi, MD, PhD, Koumei Kubo, MD, PhD, Kenichi Sawada, MD, PhD, Yoji Ishida, MD, PhD

Blood (2010) 116 (21): 1062.

https://doi.org/10.1182/blood.V116.21.1062.1062

Published: 2010

Journal Articles

API1-MALT1/MLT Is Involved in Mucosa-Associated Lymphoid Tissue Lymphoma With t(11;18)(q21;q21)

Hiroko Suzuki, Mutsuhito Motegi, Tomoaki Akagi, Yoshitaka Hosokawa, Masao Seto

Blood (1999) 94 (9): 3270–3271.

https://doi.org/10.1182/blood.V94.9.3270

Published: 1999

NARROW

Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib

Clinical Efficacy and Safety Of Dasatinib For Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase In Japan

The Prospective Analysis Of Clinical Efficacy and Adverse Events In Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Patients With Imatinib Resistance Or Intolerance, Evaluated By European Leukemia Net (ELN) 2013 Criteria

Efficacy and Safety of Dasatinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance

Micafungin Versus Voriconazole for Empirical Antifungal Therapy In Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized, Controlled Trial.

API1-MALT1/MLT Is Involved in Mucosa-Associated Lymphoid Tissue Lymphoma With t(11;18)(q21;q21)

Email alerts

ASH Publications

American Society of Hematology

Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib

Clinical Efficacy and Safety Of Dasatinib For Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase In Japan

The Prospective Analysis Of Clinical Efficacy and Adverse Events In Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Patients With Imatinib Resistance Or Intolerance, Evaluated By European Leukemia Net (ELN) 2013 Criteria

Efficacy and Safety of Dasatinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) with Imatinib Resistance or Intolerance

Micafungin Versus Voriconazole for Empirical Antifungal Therapy In Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized, Controlled Trial.

API1-MALT1/MLT Is Involved in Mucosa-Associated Lymphoid Tissue Lymphoma With t(11;18)(q21;q21)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only